The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

122 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-25

Study Completion Date

2017-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the airways and lungs that develops against harmful particles or gases with exacerbations. Coexistence of bronchiectasis with COPD may lead to worsening of the functional parameters as well as alteration of the microbiological pattern in exacerbations and may negatively affect the exacerbation result parameters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bronchiectasis Effect in COPD Patients

NCT03670940

Bronchiectasis Copd

COMPLETED

Effect of Expiratory Muscle Strength in Patients With Bronchiectasis

NCT07104942

Bronchiectasis

RECRUITING

Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects

NCT02550821

Bronchiectasis

COMPLETED

Evaluation of Medical and Nursing Management for Bronchiectasis

NCT03550417

Bronchiectasis

COMPLETED

COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic

NCT04487873

Covid19 Bronchiectasis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the airways and lungs that develops against harmful particles or gases with exacerbations. COPD exacerbations are characterized by worsening of dyspnea, coughing and expectoration. Exacerbations requiring hospitalization are the main cause of morbidity and mortality in COPD. Bronchiectasis is the irreversible extension of the bronchi. Usually follows with chronic sputum cough, airway obstruction and recurrent infection episodes. The association of bronchiectasis and COPD has long been known and its incidence is in the range of 30-50%. Coexistence of bronchiectasis with COPD may lead to worsening of the functional parameters as well as alteration of the microbiological pattern in exacerbations and may negatively affect the exacerbation result parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiectasis Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COPD exacerbation without Bronchiectasis

COPD patients who have been in exacerbation period and have no bronchiectasis

No intervention

Intervention Type OTHER

COPD exacerbation with Bronchiectasis

COPD patients who have been in exacerbation period and have bronchiectasis

No intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who underwent thoracic tomography in the last year according to index exacerbation date were included in the study

Exclusion Criteria

* Cases that mimic COPD exacerbation (pneumonia, pulmonary thromboembolism, pulmonary congestion, pneumothorax, pleural effusion, lung malignancy, asthma, asthma-COPD overlap syndrome) and patients admitted to the intensive care unit were excluded from the study.

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No